Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.
about
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulationEvidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathyClose association of water channel AQP1 with amyloid-beta deposition in Alzheimer disease brains"Hairy baskets" associated with degenerative Purkinje cell changes in essential tremorSpecific and disease stage-dependent episodic memory-related brain activation patterns in Alzheimer’s disease: a coordinate-based meta-analysisMolecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision MedicineCharacteristics of Tau and Its Ligands in PET ImagingTau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective StrategiesThe role of macropinocytosis in the propagation of protein aggregation associated with neurodegenerative diseasesBrain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participantsTDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPTClinicopathologic assessment and imaging of tauopathies in neurodegenerative dementiasNeuropathological alterations in Alzheimer diseaseThe fornix in mild cognitive impairment and Alzheimer's diseaseEarly etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction?Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy modelsEpitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8Spreading of pathology in neurodegenerative diseases: a focus on human studiesLegal but lethal: functional protein aggregation at the verge of toxicityAnalyzing dendritic spine pathology in Alzheimer's disease: problems and opportunitiesArgyrophilic grain diseaseMolecular mechanism for age-related memory loss: the histone-binding protein RbAp48Rapid changes in phospho-MAP/tau epitopes during neuronal stress: cofilin-actin rods primarily recruit microtubule binding domain epitopesNa, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly.von Economo neurones are selectively targeted in frontotemporal dementiaTrans-synaptic spread of tau pathology in vivoTARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathyAlzheimer’s disease and chronic traumatic encephalopathy: distinct but possibly overlapping disease entitiesThinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive declineMusic application alleviates short-term memory impairments through increasing cell proliferation in the hippocampus of valproic acid-induced autistic rat pups.Superficial siderosis associated with abundant τ and α-synuclein accumulation.Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP.Evaluation of alpha-synuclein immunohistochemical methods used by invited expertsInflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine.Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice.A 6.4 Mb duplication of the α-synuclein locus causing frontotemporal dementia and Parkinsonism: phenotype-genotype correlations.Arf6 controls beta-amyloid production by regulating macropinocytosis of the Amyloid Precursor Protein to lysosomesAn autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.Isolating pathogenic mechanisms embedded within the hippocampal circuit through regional vulnerability.
P2860
Q21260256-C6BC336F-DB6C-4361-AF43-DB603CB4CA58Q22251077-65C6651D-653D-4D06-9BB2-14FD4DA643BCQ24317142-1FDF3837-84A2-4032-9FC7-4EFEB4D6D847Q24628115-4F920853-532A-4378-923D-C63623139B4AQ24758018-7A775297-E652-47FE-A568-7627020F3C60Q26768648-1CA3250B-AEA0-4C62-9BAD-7F0728A710BEQ26769952-547485FC-4381-43DE-A96C-566545C6B26BQ26769957-30FC4F49-D618-4FF5-924E-A255B3DFE1B4Q26777240-23868B66-4AA4-4A81-A42C-B77B50BE8D98Q26801644-1619D00C-328D-4702-9383-D080CF9C5D30Q26851112-48DB93D4-FD24-475B-AF2C-D43809E7A982Q27003078-C7773A7E-D7D2-4F58-B11E-D19A0171CD66Q27003314-8598BE3A-7D79-4E71-9C48-69DD53A6B81FQ27015799-5752B823-051A-4107-8F6F-B6FC55697442Q27026907-232FEF6B-753F-4E03-8B2A-8E6AEC9B2986Q27308146-67361836-41EE-40A1-BB06-D93F412C0DF9Q27703671-AB315C52-85FF-44B3-A707-276482E65006Q28082279-98FB6883-22C9-4595-A6D0-35AEA841CE53Q28084859-E4FC8534-B571-43BF-873F-DEA0FED830C7Q28087158-E708FE8B-570E-42D3-9359-9E88D66C2EBAQ28266563-48B5395A-EB2D-4D4F-9F5C-7AF97F59CC20Q28297520-B24E206F-8689-4A5C-8C28-A8136C0EAE03Q28478846-E7EFA5C1-6446-416C-AEF1-CD43C0C3213CQ28572007-FA8550D9-F758-43D5-8566-67E9505914B6Q28681663-B0372F8C-B799-4433-829B-E3690275E431Q28732288-480F8212-EA19-44BE-9BA9-AC295B2B0BE2Q28749802-C0C0A89B-12C4-4E19-B44A-06CECB2B71C2Q29248301-88C048EA-FED8-4539-9C9E-0A6F446A219DQ30239789-36B391A9-7978-4871-9C25-C83E88497030Q30390564-FE898D3B-ED60-4DBC-98D6-2F7EA6F029A5Q30446486-727E327E-25F1-4C3B-A452-54ECF06F100DQ30446918-B056EF3D-7920-4649-9627-4961EA549BA8Q30483865-9EB2C673-596C-4EDD-A60C-D52A019C2492Q30488694-60E92EE1-368E-4A23-A2CD-34833B425D1BQ30524688-922AD98F-3543-4262-A54F-3646D4C2DB90Q30611779-CF84635F-EF96-481D-B8E7-120FBEAB9FD1Q30628518-170C9BF8-D656-4ED2-81EA-EC6598C4A919Q30657683-0B0A3F52-DB70-4759-BF42-1B58C7BD36C0Q30828708-06B8850D-87C9-4266-B2FA-B361740874E6Q30857122-07C2D1C1-D98C-4DD9-9B53-787D7BD07D9E
P2860
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Staging of Alzheimer disease-a ...... tions and immunocytochemistry.
@ast
Staging of Alzheimer disease-a ...... tions and immunocytochemistry.
@en
Staging of Alzheimer disease-a ...... tions and immunocytochemistry.
@nl
type
label
Staging of Alzheimer disease-a ...... tions and immunocytochemistry.
@ast
Staging of Alzheimer disease-a ...... tions and immunocytochemistry.
@en
Staging of Alzheimer disease-a ...... tions and immunocytochemistry.
@nl
prefLabel
Staging of Alzheimer disease-a ...... tions and immunocytochemistry.
@ast
Staging of Alzheimer disease-a ...... tions and immunocytochemistry.
@en
Staging of Alzheimer disease-a ...... tions and immunocytochemistry.
@nl
P2093
P2860
P1476
Staging of Alzheimer disease-a ...... tions and immunocytochemistry.
@en
P2093
Hans Kretzschmar
Heiko Braak
Irina Alafuzoff
Kelly Del Tredici
Thomas Arzberger
P2860
P2888
P304
P356
10.1007/S00401-006-0127-Z
P577
2006-08-12T00:00:00Z